Dövizler / DYN
DYN: Dyne Therapeutics Inc
13.49
USD
0.26
(1.89%)
DYN fiyatı bugün -1.89% değişti. Gün boyunca enstrüman, Düşük fiyatı olarak 13.33 ve Yüksek fiyatı olarak 13.87 aralığında işlem gördü.
Dyne Therapeutics Inc hareketlerini izleyin. Gerçek zamanlı fiyatlar, piyasa değişikliklerine hızlı bir şekilde tepki vermenize yardımcı olacaktır. Farklı zaman dilimleri arasında geçiş yaparak döviz kurunun trendlerini ve hareketlerini dakika, saat, gün, hafta ve ay bazında takip edebilirsiniz. Piyasa değişikliklerini tahmin etmek ve bilinçli alım-satım kararları vermek için bu bilgileri kullanın.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
DYN haberleri
- Dyne Therapeutics stock rises after Raymond James upgrade to Strong Buy
- Raymond James upgrades Dyne Therapeutics stock to Strong Buy on DMD therapy outlook
- Avidity Biosciences stock soars on Novartis takeover approach report
- Dyne Therapeutics stock gains as DYNE-251 receives FDA breakthrough designation
- Dyne Therapeutics stock rises after FDA grants breakthrough therapy status
- Does Dyne Therapeutics (DYN) Have the Potential to Rally 285.57% as Wall Street Analysts Expect?
- Stifel lowers Dyne Therapeutics stock price target to $36 on endpoint changes
- These Analysts Lower Their Forecasts On Dyne Therapeutics Following Q2 Loss - Dyne Therapeutics (NASDAQ:DYN)
- Dyne Reports Wider Loss in Fiscal Q2
- Dyne Therapeutics extends cash runway as it advances key drug programs
- Bernstein lowers Dyne Therapeutics stock price target on equity raise
- Tesla, Progress Software, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - AeroVironment (NASDAQ:AVAV), Dyne Therapeutics (NASDAQ:DYN)
- Tesla, AeroVironment and Progress Software fall premarket; MSC Industrial rises
- Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Argo Blockchain (NASDAQ:ARBK), Applied DNA Sciences (NASDAQ:APDN)
- Dyne Therapeutics stock falls after announcing $200 million share offering
- Dyne Therapeutics secures $275 million loan facility from Hercules Capital
- Jones Trading initiates Dyne Therapeutics stock with buy rating
- Avidity, Dyne get Bernstein ratings as oligonucleotide muscle trials advance
- Dyne Therapeutics: Emergence As A Superior DM1/DMD Player Warrants Rating Upgrade (DYN)
- H.C. Wainwright reiterates buy rating on Dyne Therapeutics stock
- Why Is Dyne Therapeutics Stock Trading Lower On Tuesday? - Dyne Therapeutics (NASDAQ:DYN)
- Dyne Therapeutics stock falls after updated plan for accelerated approval in DM1
- Dyne’s DM1 treatment receives FDA breakthrough designation
- Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET
Günlük aralık
13.33
13.87
Yıllık aralık
6.36
37.08
- Önceki kapanış
- 13.75
- Açılış
- 13.75
- Satış
- 13.49
- Alış
- 13.79
- Düşük
- 13.33
- Yüksek
- 13.87
- Hacim
- 5.062 K
- Günlük değişim
- -1.89%
- Aylık değişim
- 39.65%
- 6 aylık değişim
- -1.24%
- Yıllık değişim
- -51.40%
31 Ağustos, Pazar